{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:50:22Z","timestamp":1792839022104,"version":"4.5.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic and Interventional Imaging"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.diii.2022.05.003","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T07:59:29Z","timestamp":1663833569000},"page":"448-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["The BUMPy road of peritoneal metastases in ovarian cancer"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6398-8648","authenticated-orcid":false,"given":"Stephanie","family":"Nougaret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1976-935X","authenticated-orcid":false,"given":"Elizabeth","family":"Sadowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Lakhman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6956-2800","authenticated-orcid":false,"given":"Pascal","family":"Rousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8444-202X","authenticated-orcid":false,"given":"Max","family":"Lahaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Worley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Sgarbura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul B.","family":"Shinagare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diii.2022.05.003_bib0001","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.diii.2022.05.003_bib0002","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.diii.2022.05.003_bib0003","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.diii.2020.01.006","article-title":"Differentiation between benign and malignant ovarian masses using multiparametric MRI","volume":"101","author":"Turkoglu","year":"2020","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2022.05.003_bib0004","first-page":"280","article-title":"Epithelial ovarian cancer: evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.diii.2022.05.003_bib0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejogrb.2018.11.029","article-title":"Advanced stage (IIIC\/IV) endometrial cancer: role of cytoreduction and determinants of survival","volume":"234","author":"Rajkumar","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.diii.2022.05.003_bib0006","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","article-title":"What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma [EOC]?","volume":"103","author":"Chi","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2016.05.022","article-title":"Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: society of gynecologic oncology and American society of clinical oncology clinical practice guideline","volume":"143","author":"Wright","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0008","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumors and recurrent disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0009","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diii.2022.05.003_bib0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12957-018-1339-0","article-title":"Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index","volume":"16","author":"Llueca","year":"2018","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0011","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study","volume":"25","author":"Winter","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0012","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.01.017","article-title":"Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load [SCORPION trial]: final analysis of peri-operative outcome","volume":"59","author":"Fagotti","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.diii.2022.05.003_bib0013","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ygyno.2018.06.015","article-title":"Moving beyond \"complete surgical resection\" and \"optimal\": is low-volume residual disease another option for primary debulking surgery?","volume":"150","author":"Manning-Geist","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0014","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diii.2022.05.003_bib0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer [CHORUS]: an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.diii.2022.05.003_bib0016","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diii.2022.05.003_bib0017","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1148\/radiology.197.3.7480729","article-title":"Ovarian cancer: staging with CT and MR imaging","volume":"197","author":"Forstner","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2022.05.003_bib0018","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1148\/radiol.2232011081","article-title":"Peritoneal metastases: detection with spiral CT in patients with ovarian cancer","volume":"223","author":"Coakley","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2022.05.003_bib0019","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1148\/radiology.215.3.r00jn25761","article-title":"Staging of advanced ovarian cancer: comparison of imaging modalities\u2013report from the radiological diagnostic oncology group","volume":"215","author":"Tempany","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2022.05.003_bib0020","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00330-010-1886-4","article-title":"ESUR guidelines: ovarian cancer staging and follow-up","volume":"20","author":"Forstner","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2022.05.003_bib0021","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jacr.2007.05.019","article-title":"ACR appropriateness criteria on staging and follow-up of ovarian cancer","volume":"4","author":"Javitt","year":"2007","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.diii.2022.05.003_bib0022","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00004728-200305000-00006","article-title":"Thin section dual-phase multidetector-row computed tomography detection of peritoneal metastases in gynecologic cancers","volume":"27","author":"Pannu","year":"2003","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.diii.2022.05.003_bib0023","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.diii.2014.02.009","article-title":"Da Ines D. CT imaging of peritoneal carcinomatosis and its mimics","volume":"95","author":"Diop","year":"2014","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2022.05.003_bib0024","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygyno.2004.06.054","article-title":"Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer","volume":"96","author":"Qayyum","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00330-007-0732-9","article-title":"Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging","volume":"18","author":"Fujii","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2022.05.003_bib0026","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1148\/radiology.204.2.9240546","article-title":"Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT","volume":"204","author":"Low","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2022.05.003_bib0027","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1148\/radiology.210.3.r99mr46625","article-title":"Extrahepatic abdominal imaging in patients with malignancy: comparison of MR imaging and helical CT, with subsequent surgical correlation","volume":"210","author":"Low","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2022.05.003_bib0028","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejso.2019.02.030","article-title":"Peritoneal MRI in patients undergoing cytoreductive surgery and HIPEC: history, clinical applications, and implementation","volume":"47","author":"Low","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2019.108786","article-title":"Pre-operative evaluation of epithelial ovarian cancer: role of whole body diffusion weighted imaging MR and CT in the selection of patients suitable for primary debulking surgery","volume":"123","author":"Rizzo","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.diii.2022.05.003_bib0030","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00330-013-3083-8","article-title":"Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET\/CT","volume":"24","author":"Michielsen","year":"2014","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2022.05.003_bib0031","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejca.2017.06.010","article-title":"Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer","volume":"83","author":"Michielsen","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.diii.2022.05.003_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2019.108696","article-title":"Diffusion-weighted magnetic resonance imaging in peritoneal carcinomatosis from suspected ovarian cancer: diagnostic performance in correlation with surgical findings","volume":"121","author":"Garcia Prado","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.diii.2022.05.003_bib0033","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejrad.2019.03.007","article-title":"MRI with diffusion-weighted imaging to predict feasibility of complete cytoreduction with the peritoneal cancer index in advanced stage ovarian cancer patients","volume":"114","author":"Engbersen","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.diii.2022.05.003_bib0034","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2214\/AJR.08.1753","article-title":"Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings\u2013a feasibility study","volume":"193","author":"Low","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.diii.2022.05.003_bib0035","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejrad.2010.06.004","article-title":"Comparison of peritoneal tumor imaging using conventional MR imaging and diffusion-weighted MR imaging with different b values","volume":"80","author":"Bozkurt","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.diii.2022.05.003_bib0036","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00404-010-1442-0","article-title":"Region-based diagnostic performance of multidetector CT for detecting peritoneal seeding in ovarian cancer patients","volume":"283","author":"Choi","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.diii.2022.05.003_bib0037","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/IGC.0b013e31822925c0","article-title":"Identification and quantification of peritoneal metastases in patients with ovarian cancer with multidetector computed tomography: correlation with surgery and surgical outcome","volume":"21","author":"Metser","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.diii.2022.05.003_bib0038","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1200\/JCO.2006.07.7800","article-title":"Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer","volume":"25","author":"Axtell","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0039","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ygyno.2014.07.002","article-title":"A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer","volume":"134","author":"Suidan","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0040","article-title":"A Prediction model for optimal primary debulking surgery based on preoperative CT and clinical factors in patients with advanced ovarian cancer: a multicenter retrospective study","volume":"10","author":"Gu","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0041","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.bjc.6605292","article-title":"Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial","volume":"101","author":"Ferrandina","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.diii.2022.05.003_bib0042","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/0284185116658683","article-title":"Preoperative prediction of suboptimal resection in advanced ovarian cancer based on clinical and CT parameters","volume":"58","author":"Son","year":"2017","journal-title":"Acta Radiol"},{"key":"10.1016\/j.diii.2022.05.003_bib0043","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A","article-title":"A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography","volume":"89","author":"Bristow","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.diii.2022.05.003_bib0044","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/cncr.20376","article-title":"The utility of computed tomography in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma","volume":"101","author":"Dowdy","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.diii.2022.05.003_bib0045","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1200\/JCO.1993.11.1.166","article-title":"Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma","volume":"11","author":"Nelson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0046","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2214\/ajr.165.4.7676985","article-title":"Ovarian carcinoma: value of CT in predicting success of debulking surgery","volume":"165","author":"Meyer","year":"1995","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.diii.2022.05.003_bib0047","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00330-009-1533-0","article-title":"Multidetector CT predictors of incomplete resection in primary cytoreduction of patients with advanced ovarian cancer","volume":"20","author":"Jung","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2022.05.003_bib0048","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2017.02.020","article-title":"A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer","volume":"145","author":"Suidan","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0049","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2015.11.022","article-title":"Prediction of incomplete primary debulking surgery in patients with advanced ovarian cancer: an external validation study of three models using computed tomography","volume":"140","author":"Rutten","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0050","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2016.08.322","article-title":"Correlation of pre-operative CT findings with surgical & histological tumor dissemination patterns at cytoreduction for primary advanced and relapsed epithelial ovarian cancer: a retrospective evaluation","volume":"143","author":"Nasser","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0051","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3109\/01443615.2014.899330","article-title":"CT scan does not predict optimal debulking in stage III-IV epithelial ovarian cancer: a multicentre validation study","volume":"34","author":"MacKintosh","year":"2014","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.diii.2022.05.003_bib0052","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2015.04.013","article-title":"Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancer","volume":"138","author":"Janco","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0053","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2147\/CMAR.S166658","article-title":"Predictive significance of preoperative CT findings for suboptimal cytoreduction in advanced ovarian cancer: a meta-analysis","volume":"10","author":"Hu","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.diii.2022.05.003_bib0054","first-page":"4043","article-title":"Nomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancer","volume":"31","author":"Gerestein","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.diii.2022.05.003_bib0055","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ejso.2009.03.002","article-title":"A multicenter validation of computerized tomography models as predictors of non- optimal primary cytoreduction of advanced epithelial ovarian cancer","volume":"35","author":"Gemer","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0056","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/ijgc-2018-000054","article-title":"Development of a preoperative computed tomography score for the management of advanced epithelial ovarian cancer","volume":"29","author":"Fuso","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.diii.2022.05.003_bib0057","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00404-011-1864-3","article-title":"Usefulness of computed tomography in predicting cytoreductive surgical outcomes for ovarian cancer","volume":"284","author":"Fujwara","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.diii.2022.05.003_bib0058","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/1471-0528.12992","article-title":"Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer","volume":"122","author":"Borley","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.diii.2022.05.003_bib0059","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.diii.2021.05.007","article-title":"Diffusion-weighted MRI and PET\/CT reproducibility in epithelial ovarian cancers during neoadjuvant chemotherapy","volume":"102","author":"Crombe","year":"2021","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2022.05.003_bib0060","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2214\/AJR.10.4687","article-title":"Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET\/CT, diffusion-weighted MRI, and contrast-enhanced MDCT","volume":"196","author":"Satoh","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.diii.2022.05.003_bib0061","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2009.10.059","article-title":"Diagnosis and staging of primary ovarian cancer: correlation between PET\/CT, Doppler US, and CT or MRI","volume":"116","author":"Nam","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0062","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2013.08.023","article-title":"A prospective comparison of integrated FDG-PET\/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer","volume":"131","author":"Hynninen","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0063","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejrad.2007.11.032","article-title":"Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET\/MDCT","volume":"69","author":"Dirisamer","year":"2009","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.diii.2022.05.003_bib0064","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ygyno.2013.08.020","article-title":"PET\/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer","volume":"131","author":"Dauwen","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0065","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MNM.0b013e3281afa256","article-title":"Diagnostic accuracy of 18F-FDG PET\/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology","volume":"28","author":"Castellucci","year":"2007","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.diii.2022.05.003_bib0066","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1007\/s00259-008-0890-2","article-title":"Diagnostic accuracy of integrated FDG-PET\/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT","volume":"35","author":"Kitajima","year":"2008","journal-title":"Eur J Nucl Med and Mol imaging"},{"key":"10.1016\/j.diii.2022.05.003_bib0067","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1007\/s00261-015-0418-8","article-title":"Comparison of PET with PET\/CT in detecting peritoneal carcinomatosis: a meta-analysis","volume":"40","author":"Li","year":"2015","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.diii.2022.05.003_bib0068","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s13244-010-0062-3","article-title":"Causes and imaging features of false positives and false negatives on F-PET\/CT in oncologic imaging","volume":"2","author":"Long","year":"2011","journal-title":"Insights Imaging"},{"key":"10.1016\/j.diii.2022.05.003_bib0069","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2214\/ajr.119.1.198","article-title":"Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid","volume":"119","author":"Meyers","year":"1973","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"10.1016\/j.diii.2022.05.003_bib0070","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1148\/rg.326125511","article-title":"Ovarian carcinomatosis: how the radiologist can help plan the surgical approach","volume":"32","author":"Nougaret","year":"2012","journal-title":"Radiographics"},{"key":"10.1016\/j.diii.2022.05.003_bib0071","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1148\/rg.2016150186","article-title":"The wheel of the mesentery: imaging spectrum of primary and secondary mesenteric neoplasms\u2013How can radiologists help plan treatment?","volume":"36","author":"Nougaret","year":"2016","journal-title":"Radiographics"},{"key":"10.1016\/j.diii.2022.05.003_bib0072","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","article-title":"Aggressive surgical effort and improved survival in advanced-stage ovarian cancer","volume":"107","author":"Aletti","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.diii.2022.05.003_bib0073","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diii.2022.05.003_bib0074","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejso.2008.01.005","article-title":"Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients","volume":"35","author":"Colombo","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00261-007-9211-7","article-title":"Staging of peritoneal carcinomatosis: enhanced CT vs. PET\/CT","volume":"33","author":"Dromain","year":"2008","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.diii.2022.05.003_bib0076","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/1522-2586(200008)12:2<269::AID-JMRI9>3.0.CO;2-G","article-title":"Extrahepatic abdominal imaging in patients with malignancy: comparison of MR imaging and helical CT in 164 patients","volume":"12","author":"Low","year":"2000","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.diii.2022.05.003_bib0077","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/bjs.10527","article-title":"Evaluation of the peritoneal carcinomatosis index with CT and MRI","volume":"104","author":"Dohan","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.diii.2022.05.003_bib0078","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00261-017-1158-8","article-title":"Prognostic significance of supradiaphragmatic lymph nodes at initial presentation in patients with stage III high-grade serous ovarian cancer","volume":"42","author":"McIntosh","year":"2017","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.diii.2022.05.003_bib0079","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2017.10.024","article-title":"Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: implications for survival","volume":"148","author":"Mert","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2016.03.012","article-title":"Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer","volume":"141","author":"Prader","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0081","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1148\/radiol.2482070371","article-title":"Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion","volume":"248","author":"Akin","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2022.05.003_bib0082","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1148\/radiol.2016152595","article-title":"Patterns and prognostic importance of Hepatic involvement in patients with serous ovarian cancer: a single-institution experience with 244 patients","volume":"282","author":"O'Neill","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2022.05.003_bib0083","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1055-3207(03)00048-6","article-title":"Peritonectomy procedures","volume":"12","author":"Sugarbaker","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.diii.2022.05.003_bib0084","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/jso.21484","article-title":"Surgical responsibilities in the management of peritoneal carcinomatosis","volume":"101","author":"Sugarbaker","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0085","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000658-199502000-00002","article-title":"Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.diii.2022.05.003_bib0086","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7800-2-3","article-title":"Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer","volume":"2","author":"Harmon","year":"2005","journal-title":"Int Semin Surg Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0087","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/ejso.2002.1380","article-title":"Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer","volume":"29","author":"Tentes","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0088","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","article-title":"Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study","volume":"90","author":"Eisenkop","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0089","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1245\/ASO.2006.08.021","article-title":"A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study","volume":"13","author":"Fagotti","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0090","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ygyno.2008.04.042","article-title":"External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score","volume":"110","author":"Brun","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0091","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2007.05.032","article-title":"A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model","volume":"107","author":"Aletti","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.10.856","article-title":"Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer","volume":"202","author":"Chereau","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.diii.2022.05.003_bib0093","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","article-title":"Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis","volume":"16","author":"Koh","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0094","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11547-020-01170-6","article-title":"Radiological assessment of peritoneal cancer index on preoperative CT in ovarian cancer is related to surgical outcome and survival","volume":"125","author":"Avesani","year":"2020","journal-title":"Radiol Med"},{"key":"10.1016\/j.diii.2022.05.003_bib0095","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1007\/s00261-019-01939-y","article-title":"Extended abdominopelvic MRI versus CT at the time of adnexal mass characterization for assessing radiologic peritoneal cancer index prior to cytoreductive surgery","volume":"44","author":"Gadelhak","year":"2019","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.diii.2022.05.003_bib0096","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1245\/s10434-014-4041-7","article-title":"Comparison of MRI and CT for predicting the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures","volume":"22","author":"Low","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0097","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s13193-019-00914-9","article-title":"Accuracy of CT in predicting surgical PCI in patients undergoing cytoreductive surgery with\/without HIPEC: a prospective single institution study","volume":"10","author":"Goswami","year":"2019","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0098","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s00261-013-0013-9","article-title":"Accuracy of MDCT in the preoperative definition of peritoneal cancer index in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy [HIPEC]","volume":"38","author":"Mazzei","year":"2013","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.diii.2022.05.003_bib0099","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.acra.2019.04.005","article-title":"The accuracy of multi-detector computed tomography and laparoscopy in the prediction of peritoneal carcinomatosis index score in primary ovarian cancer","volume":"26","author":"Ahmed","year":"2019","journal-title":"Acad Radiol"},{"key":"10.1016\/j.diii.2022.05.003_bib0100","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1007\/s00261-016-0817-5","article-title":"Prediction of 5-year survival in advanced-stage ovarian cancer patients based on computed tomography peritoneal carcinomatosis index","volume":"41","author":"Diaz-Gil","year":"2016","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.diii.2022.05.003_bib0101","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ejso.2016.03.015","article-title":"A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy stage evaluation [PROMISE] application","volume":"42","author":"Villeneuve","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.diii.2022.05.003_bib0102","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.diii.2022.05.003_bib0103","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/GCO.0000000000000340","article-title":"Pathogenesis and heterogeneity of ovarian cancer","volume":"29","author":"Kroeger","year":"2017","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.diii.2022.05.003_bib0104","first-page":"517","article-title":"Prognostically relevant gene signatures of high-grade serous ovarian carcinoma","volume":"123","author":"Verhaak","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diii.2022.05.003_bib0105","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1148\/radiol.2017161870","article-title":"Radiogenomics of high-grade serous ovarian cancer: multireader multi-institutional study from the cancer genome atlas ovarian cancer imaging research group","volume":"285","author":"Vargas","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2022.05.003_bib0106","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1148\/radiol.2017161697","article-title":"High-grade serous ovarian cancer: associations between BRCA mutation status, CT imaging phenotypes, and clinical outcomes","volume":"285","author":"Nougaret","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2022.05.003_bib0107","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1007\/s00330-018-5389-z","article-title":"Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 months","volume":"28","author":"Rizzo","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2022.05.003_bib0108","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.diii.2020.10.007","article-title":"Artificial intelligence: from challenges to clinical implementation","volume":"101","author":"Chassagnon","year":"2020","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2022.05.003_bib0109","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.diii.2021.06.005","article-title":"Three artificial intelligence data challenges based on CT and ultrasound","volume":"102","author":"Lassau","year":"2021","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2022.05.003_bib0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.diii.2019.09.002","article-title":"Deep lessons learned: radiology, oncology, pathology, and computer science experts unite around artificial intelligence to strive for earlier pancreatic cancer diagnosis","volume":"101","author":"Weisberg","year":"2020","journal-title":"Diagn Interv Imaging"}],"container-title":["Diagnostic and Interventional Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211568422000936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211568422000936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:38:03Z","timestamp":1761932283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211568422000936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":110,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2211568422000936"],"URL":"https:\/\/doi.org\/10.1016\/j.diii.2022.05.003","relation":{},"ISSN":["2211-5684"],"issn-type":[{"value":"2211-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The BUMPy road of peritoneal metastases in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Diagnostic and Interventional Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diii.2022.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radiologie.","name":"copyright","label":"Copyright"}]}}